Escherichia coli type III secretion system 2: a new kind of T3SS? by Mingxu Zhou et al.
VETERINARY RESEARCH
Zhou et al. Veterinary Research 2014, 45:32
http://www.veterinaryresearch.org/content/45/1/32REVIEW Open AccessEscherichia coli type III secretion system 2: a new
kind of T3SS?
Mingxu Zhou1,2, Zhiyan Guo1,2, Qiangde Duan1,3, Philip R Hardwidge4 and Guoqiang Zhu1,2*Abstract
Type III secretion systems (T3SSs) are employed by Gram-negative bacteria to deliver effector proteins into the cytoplasm
of infected host cells. Enteropathogenic Escherichia coli use a T3SS to deliver effector proteins that result in the creation
of the attaching and effacing lesions. The genome sequence of the Escherichia coli pathotype O157:H7 revealed the
existence of a gene cluster encoding components of a second type III secretion system, the E. coli type III secretion
system 2 (ETT2). Researchers have revealed that, although ETT2 may not be a functional secretion system in most
(or all) strains, it still plays an important role in bacterial virulence. This article summarizes current knowledge regarding
the E. coli ETT2, including its genetic characteristics, prevalence, function, association with virulence, and prospects for
future work.Table of contents
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Many pathogenic Gram-negative bacteria utilize type III
secretion systems (T3SSs) to subvert eukaryotic signal-
ing pathways by injecting virulence proteins into the
host cell cytoplasm [1-5]. Intracellular pathogens, such
as Salmonella, Shigella, and Chlamydia, use T3SS for at-
tachment to and/or invasion of host cells [6-8]. Yersinia
enterocolitica and Yersinia pseudotuberculosis induce* Correspondence: yzgqzhu@yzu.edu.cn
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unless otherwise stated.macrophage apoptosis and subvert host innate immun-
ity by injecting effectors through the T3SS [9-11]. En-
teropathogenic E. coli (EPEC) and enterohemorrhagic
E. coli (EHEC) use the T3SS to deliver effector proteins
that result in the creation of the attaching and effacing
(A/E) lesions [12,13]. Salmonella utilize multiple type
III secretion systems, with the first, Salmonella patho-
genicity islands 1 (SPI-1) T3SS, playing a role in inva-
sion into host cells, while the second, SPI-2 T3SS, is
important for intracellular survival [14]. The complete
genome sequencing of two EHEC O157:H7 strains,
EDL933 and Sakai, revealed the presence of a gene clus-
ter predicted to encode an additional T3SS. This T3SS
was designated as the E. coli type III secretion system 2
(ETT2), to distinguish it from the locus of enterocyte
effacement (LEE) - encoded T3SS, which is now called
ETT1 [15,16].
EHEC and other Shiga-like toxin-producing E. coli
(STEC), including the O157:H7 serotype, are responsible
for diseases in humans and animals whose clinical
spectrum includes diarrhea, hemorrhagic colitis, and
hemolytic uremic syndrome (HUS) [17-20]. There are
no proven effective treatments, and administering an-
tibiotics is often contraindicated because they may en-
hance the progression of enteritis to HUS [21]. While the
function of the EHEC ETT1 has been well characterized
[22-25], the function of ETT2 and its role in virulence is
less clear.td. This is an Open Access article distributed under the terms of the Creative
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of ETT2
The genes required for ETT1 function, including the
T3SS apparatus and the secreted proteins, are encoded
on the LEE in EPEC and EHEC. This virulence locus
is about 35.4-kb in size and contains 41 open reading
frames (ORFs) [24-26]. Up to 32 other non-LEE-encoded
effector proteins can also be delivered into host cells by
the ETT1 to subvert eukaryotic cell biology [27]. The
ETT2 is approximately 29.9-kb in size and is adjacent
to the tRNA locus glyU on the bacterial chromosome
(Figure 1). The ETT2 gene cluster includes at least 35
ORFs, from ECs3703 to ECs3737 in the Sakai strain
(GenBank: NC_002695; Table 1). The G + C content
of the ETT2 sequence is lower (36.9%) than that of
the E. coli chromosome (50.8%), suggesting that the
ETT2 gene cluster was a pathogenicity island inserted
into EHEC O157:H7 strains [28,29].
It has been shown that the ETT2 gene cluster exists in
whole or in part in the majority of E. coli strains, regard-
less of their pathogenicity, but with significant variability
[29-31]. Sequence alignment analysis revealed that the
ETT2 with all 35 ORFs in the Sakai strain also contains
some pseudogenes, while EAEC 042 not (Figure 1, [31]).
Cheng divided ETT2 variants into 11 isoforms (desig-
nated as type A to type K), with type A representing the
complete ETT2 island with 35 ORFs [32].
3. Prevalence and distribution of ETT2
The ETT2 gene cluster is primarily associated with
STEC strains. Hartleib et al. detected the presence of
ETT2 locus in 245 strains of E. coli, in 25 strains of
Salmonella enterica, and in 10 other bacteria, using
both PCR and Southern blotting. The ETT2 was dis-
tributed ubiquitously among intestinal E. coli strains,
but not in extra-intestinal (including serotypes O2:H7,
O6:H12, O18:H7) or non-pathogenic (including sero-
types O5, O74) E. coli strains or in other enteric bac-
teria such as Salmonella, Yersinia, and Shigella [28].
Serotype O55:H7 strains were shown to be the most
recent precursors of the virulent O157:H7 EHEC strainsFigure 1 Structure of ETT2 gene cluster in strain EHEC Sakai and EAE
and is adjacent to the tRNA locus glyU on the bacterial chromosome. Fram
coding for a transcriptional regulator, blue indicates gene encoding other p[33]. BLAST Genome on NCBI revealed O55:H7 EPEC
strains share 49% fragment of the intact ETT2 cluster, los-
ing almost all genes from ECs3711 to ECs3731 (Table 1).
Genome analysis also showed that, all whole-genome
sequenced EPEC strains (except serotype O127:H6) and
STEC (including serotypes both O157 and non-O157)
strains carry the ETT2 gene cluster.
ETT2 is prevalent in a majority of characterized hu-
man diarrheagenic E. coli isolates (54/83; 65%), and all
STEC strains tested (except serotype O177) contain the
ETT2 gene cluster [34]. However, ETT2 prevalence in
uropathogenic E. coli (UPEC) strains is low [35].
In animal originated E. coli strains, ETT2 is also com-
mon. Cheng et al. isolated 92 pathogenic E. coli strains
from weaned piglets with edema and/or diarrhea and
76 pathogenic E. coli strains from dairy cows with
clinical or sub-clinical mastitis and detected the ETT2
ORFs by PCR. Most isolates (85.9%) from piglets con-
tained an intact or partial ETT2 gene cluster, signifi-
cantly higher than those isolated from cows (47.4%)
[32]. Prager also identified ETT2 loci in 117 STEC strains
originating from piglets suffering from edema disease or
colibacillosis [30].
4. Putative functions of the ETT2
4.1 ETT2 encodes a functional secretion system?
The T3SSs are comprised of a basal body that spans the
cell membranes and a needle-like complex that extends
from the outer membrane, through which effectors are
secreted. The basal body consists of an inner ring, an
outer ring, and a neck that spans the periplasm. A func-
tional T3SS requires additional elements, including a
cytosolic regulatory complex linked to the basal body, an
inner rod that constitutes the base of the needle, and a
translocon protein complex that forms a pore in the host
membrane [36].
The ETT2 gene cluster was originally regarded as a
SPI-1-like island, of which 19 ORFs are highly homolo-
gous with the SPI-1 T3SS of Salmonella enterica serovar
Typhmurium [37,38]. However, some significant differ-
ences exist between the E. coli ETT2 and SPI-1 T3SS:C 042. The ETT2 gene cluster includes 35 ORFs (ECs3703 – Ecs3737)
e in yellow indicates gene encoding a chaperone, red indicates gene
athogenicity island (PAI) gene, stripe indicated gene is a pseudogene.
Table 1 Homologs and putative functions of ETT2 ORFs
Gene in Sakai
strain
Length (bp) Homologs* Putative function
ECs3703 693 yqeH




ECs3708 492 ygeG,sicA Chaperone
ECs3709 1377 ygeH Transcriptional regulator
ECs3710 219 B2853





ECs3714 261 B2858, orgB
ECs3715 582 B2859, orgA
ECs3716/eprK 735 prgK Lipoprotein precursor
ECs3717/eprJ 333 prgJ, mxiI
ECs3718/eprI 240 prgI, mxiH
ECs3719/eprH 735 prgH, mxiG
ECs3720/etrA 501 ntrC Transcriptional regulator





ECs3725/epaP 666 spaP Surface presentation of
antigens protein





ECs3730/eivC 1320 spaI/invC Invasion protein
ECs3731/eivA 2061 invA
ECs3732/eivE 1146 invE Invasion protein
ECs3733/eivG 1704 invG
ECs3734/eivF 750 invF Transcriptional regulator
ECs3735 180 ydcX Inner membrane protein
ECs3736/pkgA 1059 B2863 Phosphorylase kinase
and glucoamylase
ECs3737 606 B2862
*yqeHIJK, ygeFGH, ydcX, B2853, B2354, B2356-B2359, B2362, and B2363 are
conserved genes in E. coli K-12. orgA, orgB, iagB, prgHIJK, spaOPQRS, invA, invC,
invE, invF, invG, invI, and invJ are Salmonella enterica SPI-1 genes. mxiI, mxiG
and mxiH are Shigella flexneri genes. ntrC is from Herbaspirillum seropedicae.
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two ORFs, epaR1 and epaR2, in the ETT2 gene cluster,
and (ii) invB and invH are absent from the ETT2 gene
cluster. In the Salmonella SPI-1 T3SS, InvB is required
for secretion and translocation of SopE and SopE2 and
for stabilization of SopE2 in the bacterial cytosol [39].
InvH is necessary for localization of InvG to the outer
membrane, but InvH is not a component of the type III
secretion apparatus [40]. Several important T3SS struc-
tural genes, including prgH (encoding the inner ring)
and sipABCD (encoding the needle tip and translocon),
are disrupted by frameshifts or are absent [41]. Thus,
it appears that this partial ETT2 gene cluster itself
does not encode a functional secretion system in EHEC
O157 [31].
Nevertheless, even if some necessary genes are missing
or nonfunctional in ETT2, it seems possible that genes
in ETT1 might complement those gene functions, in
order to construct a working apparatus for secretion.
Otherwise, pkgA, a gene at one end of ETT2 cluster en-
coding a putative glucoamylase that targets glycogen
metabolism within host cell was identified, and specu-
lated to be a ETT2 effector [42]. Another four putative
effector genes disrupted by frameshifts in EHEC were
found in the EAEC 042 as well, indicating there still has
possibility of secretion ability of ETT2 in the future [43].
4.2 ETT2 regulates bacterial virulence
However, the ETT2 still plays a crucial role in virulence.
Co-regulation between the T3SSs is important to Sal-
monella biology. Normally, effectors encoded in SPI-1
are translocated specifically by the SPI-1 T3SS and effec-
tors encoded in SPI-2 are translocated specifically by the
SPI-2 T3SS. Interestingly, sometimes, the Salmonella
T3SS translocates certain proteins encoded not only in
SPI-1, but also outside the locus [44,45]. SPI-2 T3SS
could translocate both effectors encoded in SPI-1 and
SPI-2. The ETT2 gene cluster can also regulate genes
encoded elsewhere on the chromosome.
Zhang et al. targeted the ygeH (ECs3709), etrA
(ECs3720), and eivF (ECs3734) genes of the Sakai 813
strain, and demonstrated the negative effects on gene
transcription within the LEE by EtrA and EivF: deletion
of etrA and eivF led to increased secretion of proteins
encoded by the LEE and to increased adhesion to human
intestinal cells [46].
The degenerate ETT2 gene cluster from E. coli O157:
H7 can not only regulate the expression of virulence-
associated genes encoded elsewhere, but also can affect
bacterial virulence. Ideses et al. compared the virulence
of WT E. coli 789 with ETT2 deletion mutants in 1-day-
old chickens and found that the ETT2 mutant was sub-
stantially attenuated [47]. Yao et al. deleted either the
entire ETT2 gene cluster or only eivA (ECs3732) gene in
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served that the ETT2 deletion mutant exhibited both a
50% reduction in invasion and an 80% decrease in intra-
cellular survival in human brain microvascular endothe-
lial cells (HBMECs) as compared with WT EC10 [48],
which indicated that ETT2 is necessary in the patho-
genic process of E. coli stain K1 interacting with host
cells. Sheikh et al. also reported that a hilA (encoding
a Salmonella enterica regulator) homolog, eilA, coor-
dinately activated both the EivF, EivA and presum-
ably other effectors encoded elsewhere on the genome
(adjacent to tRNA locus selC), influencing both bacter-
ial adherence to epithelial cells and biofilm formation,
which indirectly suggested the role of ETT2 in bacterial
virulence [49,50].
4.3 Association of ETT2 with other virulence factors
In the veterinary field, as the ETT2 is primarily associ-
ated with EHEC and STEC, it is common to find Stx2e
in ETT2 positive strains [32]. In other pathogenic E. coli
of different O: H serotypes, the ETT2 island is also asso-
ciated with one or more pathogenicity islands, such as
LEE, HPI and LPA [28].
Prager et al. investigated 266 STEC isolates from various
human clinical sources and found that different virulence
genes were associated with the ETT2. Some genes, includ-
ing stx2d (encoding a Shiga toxin activated by elastase)
occur alone or in combinations with ETT2 or LPA, but
never with the LEE [51]. It will be important to confirm
whether the expression and/or secretion of these virulence
factors are affected by the ETT2 island.
5. Conclusions
The ETT2 is prevalent in pathogenic EHEC and STEC
strains and is likely important to both human and veter-
inary medicine. While the exact function of the ETT2
has not been defined clearly, rather than encoding a se-
cretion system, recent work has demonstrated its im-
portance to bacterial adherence and in regulating the
expression of other virulence factors, and further study
of the ETT2 may help to elucidate details governing
bacterial virulence gene regulation. While most sero-
types of E. coli carry an impaired ETT2 gene cluster,
the presence of an intact ETT2 might be used to iden-
tify highly-pathogenic EHEC or STEC strains and for
molecular fingerprinting of epidemic strains in humans
and animals.
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